Circulating Biomarkers in Elderly Patients with Heart Failure: A Real-Life Study

Preprints.org 2026 Preprint Open access

Read full text
Authors: Velia Cassano, Caterina Gabriele, Maria Rosangela Scarcelli, Giuseppe Armentaro, Giandomenico Severini, Domenico Martire, Carlo Alberto Pastura, Sofia Miceli, Marta Letizia Hribal, Giuseppe M.C. Rosano, Marco Gaspari, Angela Sciacqua
DOI: 10.20944/preprints202601.1855.v1
Cited by: 1

Abstract

BACKGROUND: Heart failure (HF) is a clinical syndrome that involves multiple interconnected pathways. Circulating biomarkers in HF emerged as powerful tools for risk stratification, diagnostic confirmation, prognostic assessment, and monitoring of treatment efficacy. The aim of the present study was to evaluate circulating levels of biomarkers in elderly patients with HF improved ejection fraction, previously with left ventricular ejection fraction (LVEF)

Fields of Study & Subjects

Cardiac Fibrosis and Remodeling Heart Failure Treatment and Management GDF15 and Related Biomarkers

Publication details

Journal / source
Preprints.org
Publisher
MDPI AG
Publication date
26 January 2026
Document type
Preprint